Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer


Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.

ColonFlag is a solution that identifies patients who may experience gastrointestinal microbleeding caused by polyps or cancer. A positive result is an indication for colonoscopy.

ColonFlag helps make diagnostic decisions thanks to applying advanced AI algorithms to data from frequently performed laboratory tests. The programme analyses data such as the results of a CBC test and other data contained in electronic medical records.

- Dr Piotr Soszyński, Director of Medical Systems at Medicover Polska

This makes it possible for the tool to identify people who are in a high risk group and require further testing.

Colon cancer is the second most common cancer in women in Poland and the third among males. It is the fourth most common cause of death due to cancer. In Poland, the average survival rate after five years is slightly below 50%. If colorectal cancer is diagnosed at an early stage, the rate may even exceed 90%. Early detection has enormous importance for the successful treatment of colorectal cancer. ColonFlag can help us better identify patients in the high risk group. Thanks to this, referrals for colonoscopy may result in a better chance of detecting the disease and significantly improve the outcome of treatment.

- Dr Bożena Walewska-Zielecka, Medical Director at Medicover Polska

The success of the project may mean that Medicover Polska will begin using the ColonFlag tool in routine diagnostic procedures.

We are pleased to be working with Medicover on their first use of machine-learning algorithms to streamline the processes of diagnostic decision making. This is the first step towards integrating technology that will have a far-reaching impact on the work of doctors and medical service providers. It will give them tools to provide individualised care for patients in the high risk group. - Ori Geva, CEO of Medial EarlySign.
The pilot programme using the innovative method is being implemented at Medicover Centres in Warsaw and in the south of Poland. The single analysis is performed in Medicover patients between the ages of 50 and 75 who have had a complete blood count test performed for any reasons and agreed to participate in the project. Medial EarlySign is currently conducting clinical trials in more than 20 million patients in 14 institutions around the world.

Copy as a Plain Text


Related Stories
The Medicover Hospital accredited by the Ministry of Health


Medicover Hospital for the third time received the accreditation of the Ministry of Health confirming the high quality of treatment and patient safety. The accreditation process consists of an external evaluation of the institution work, which is performed by the Centre for Quality Monitoring in Health Care - unit of the Ministry of Health. The accreditation is granted for a period of three years. Currently, 203 of 1200 hospitals in Poland have accreditation certificate.
Do you have tender and bleeding gums or increased tooth mobility? Contact a specialist. These may be symptoms of periodontitis


Gum disease (periodontitis) is, along with caries, one of Poles' most common dental diseases, affecting nearly 50% of adult patients. Although the problem is serious, only one in ten of us is diagnosed or treated for this condition [1]. Undiagnosed and untreated periodontitis has very serious consequences. When untreated, it may even lead to tooth loss, so it is worthwhile to pay more attention to the prevention of periodontal disease. [1] 
Wrocław's Royal Dent joins the dental network of Medicover Stomatologia


At the beginning of July, Medicover Stomatologia took over another dental clinic. This time, it is Wrocław's Royal Dent clinic, which specializes in the cutting-edge procedures and technologies in the fields of dental implantology and orthodontics. Among them, we find the Incognito and Invisalign systems, globally recognized solutions for fixed orthodontic appliances, which provide comfort and increase the effectiveness of treatment.
Medicover Poland and Patronite join forces


Medicover Polska has started cooperation with Patronite – an online platform that connects creators with people who support their work. As part of the collaboration, a special offer of medical care for creators has been prepared. There will also be competitions for members of the community with annual healthcare packages as prizes.
Check your inbox for a subscription confirmation email.
By confirming your subscription you will receive the latest content published on this website and consent to your information being securely processed and stored.